Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fairfax Identity Laboratories (FIL) was a prominent provider of DNA identification services, specializing in forensic casework and relationship testing. Operating as a division of the Genetics & IVF Institute (GIVF), the laboratory offered a comprehensive suite of genetic tests including paternity, maternity, and kinship analysis for legal and private purposes. FIL was highly regarded for its quality standards, maintaining accreditations from the AABB and the American Society of Crime Laboratory Directors/Laboratory Accreditation Board (ASCLD/LAB). In 2017, the forensic DNA division of FIL was acquired by Sorenson Forensics, which integrated FIL's expertise and client base into its own operations. The company played a significant role in the growth of the private DNA testing industry, serving law enforcement, legal professionals, and the general public.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fairfax Identity Labs.